We are live on ! Find out more
DA

Dillon & Associates Portfolio holdings

AUM $726M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
+1.95%
1 Year Est. Return
+18.59%
3 Year Est. Return
+92.03%
5 Year Est. Return
+130.73%
10 Year Est. Return
+511.58%
AUM
$329M
AUM Growth
+$5.16M
Cap. Flow
+$307K
Cap. Flow %
0.09%
Top 10 Hldgs %
46.75%
Holding
67
New
1
Increased
30
Reduced
25
Closed
–

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$1.05M
2
AMZN icon
Amazon
AMZN
+$547K
3
RTX icon
RTX Corp
RTX
+$504K
4
PAYC icon
Paycom
PAYC
+$412K
5
EEFT icon
Euronet Worldwide
EEFT
+$385K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$1M
2
UPS icon
United Parcel Service
UPS
+$979K
3
CTSH icon
Cognizant
CTSH
+$856K
4
JPM icon
JPMorgan Chase
JPM
+$437K
5
JNJ icon
Johnson & Johnson
JNJ
+$391K

Sector Composition

Rank Sector Weight
1 Technology 23.26%
2 Healthcare 20.14%
3 Consumer Staples 10.38%
4 Communication Services 10.34%
5 Consumer Discretionary 10.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
51
Biogen
BIIB
$30B
$437K 0.13%
1,876
-930
-33% -$217K
CSCO icon
52
Cisco
CSCO
$457B
$425K 0.13%
8,683
– –
KO icon
53
Coca-Cola
KO
$377B
$417K 0.13%
7,727
-50
-0.6% -$2.68K
CTSH icon
54
Cognizant
CTSH
$24.9B
$355K 0.11%
5,923
-13,549
-70% -$856K
TGT icon
55
Target
TGT
$65.6B
$310K 0.09%
2,900
-25
-0.9% -$2.38K
ETN icon
56
Eaton
ETN
$161B
$303K 0.09%
3,646
-700
-16% -$56.7K
XOM icon
57
ExxonMobil
XOM
$644B
$282K 0.09%
3,967
– –
EMR icon
58
Emerson Electric
EMR
$83.9B
$265K 0.08%
3,957
-100
-2% -$6.29K
ADBE icon
59
Adobe
ADBE
$99.5B
$263K 0.08%
954
+134
+16% +$39.1K
MRK icon
60
Merck
MRK
$322B
$263K 0.08%
3,280
– –
CELG
61
DELISTED
Celgene Corp
CELG
$263K 0.08%
2,659
-10,534
-80% -$1M
ENB icon
62
Enbridge
ENB
$119B
$246K 0.07%
7,025
-400
-5% -$13.8K
UNH icon
63
UnitedHealth
UNH
$376B
$239K 0.07%
1,100
– –
BRK.B icon
64
Berkshire Hathaway Class B
BRK.B
$1.1T
$215K 0.07%
1,034
+37
+4% +$7.62K
IMNN icon
65
Imunon
IMNN
$6.68M
$45K 0.01%
114
– –
RMTI icon
66
Rockwell Medical
RMTI
$28.4M
$34K 0.01%
+104
New +$32K
GCVRZ
67
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$6K ﹤0.01%
10,260
– –
1 2
3

Similar funds

TC
Torno Capital Cohasset, Massachusetts $725M AUM 62.71% 1-Year Est. Return
F
FIFTHDELTA London, United Kingdom $725M AUM 11.7% 1-Year Est. Return
SDH
Sloy Dahl & Holst Vancouver, Washington $728M AUM 37.66% 1-Year Est. Return
SCM
SKBA Capital Management San Francisco, California $728M AUM 12.18% 1-Year Est. Return
MWP
Meridian Wealth Partners Exton, Pennsylvania $729M AUM 15.61% 1-Year Est. Return
FAN
Financial Advisors Network Tustin, California $724M AUM 14.91% 1-Year Est. Return
TFHU
TLT Family Holdco ULC Toronto $724M AUM 24.23% 1-Year Est. Return
AGAM
Avalon Global Asset Management San Francisco, California $724M AUM 52.97% 1-Year Est. Return

Dillon & Associates's Q3 2019 Portfolio in Review

As of Q3 2019, Dillon & Associates held 67 positions worth $329M, up 1.6% from $323M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 1.5%. Dillon & Associates opened 1 new position and made no exits, leaving the 67-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Dillon & Associates's largest Q3 2019 buy was Rockwell Medical: 104 shares worth $34K.
  • Dillon & Associates added most to Meta Platforms (Facebook) in Q3 2019, an estimated $1.05M increase.
  • Dillon & Associates's biggest Q3 2019 reduction was Celgene Corp, cutting an estimated $1M.
  • Dillon & Associates's ten largest holdings make up 47% of its $329M portfolio in Q3 2019.
  • Dillon & Associates opened 1 new position and closed 0 in Q3 2019.
  • Dillon & Associates's portfolio value rose 1.6% quarter-over-quarter to $329M.

Based on Dillon & Associates's 13F filing for Q3 2019, filed 25 Oct 2019.